221 related articles for article (PubMed ID: 21185110)
1. 2-hydroxyisoquinoline-1,3(2H,4H)-diones as inhibitors of HIV-1 integrase and reverse transcriptase RNase H domain: influence of the alkylation of position 4.
Billamboz M; Bailly F; Lion C; Calmels C; Andréola ML; Witvrouw M; Christ F; Debyser Z; De Luca L; Chimirri A; Cotelle P
Eur J Med Chem; 2011 Feb; 46(2):535-46. PubMed ID: 21185110
[TBL] [Abstract][Full Text] [Related]
2. Magnesium chelating 2-hydroxyisoquinoline-1,3(2H,4H)-diones, as inhibitors of HIV-1 integrase and/or the HIV-1 reverse transcriptase ribonuclease H domain: discovery of a novel selective inhibitor of the ribonuclease H function.
Billamboz M; Bailly F; Lion C; Touati N; Vezin H; Calmels C; Andréola ML; Christ F; Debyser Z; Cotelle P
J Med Chem; 2011 Mar; 54(6):1812-24. PubMed ID: 21366258
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of a series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones as dual inhibitors of human immunodeficiency virus type 1 integrase and the reverse transcriptase RNase H domain.
Billamboz M; Bailly F; Barreca ML; De Luca L; Mouscadet JF; Calmels C; Andréola ML; Witvrouw M; Christ F; Debyser Z; Cotelle P
J Med Chem; 2008 Dec; 51(24):7717-30. PubMed ID: 19053754
[TBL] [Abstract][Full Text] [Related]
4. 2-Hydroxyisoquinoline-1,3(2H,4H)-diones (HIDs), novel inhibitors of HIV integrase with a high barrier to resistance.
Desimmie BA; Demeulemeester J; Suchaud V; Taltynov O; Billamboz M; Lion C; Bailly F; Strelkov SV; Debyser Z; Cotelle P; Christ F
ACS Chem Biol; 2013; 8(6):1187-94. PubMed ID: 23517458
[TBL] [Abstract][Full Text] [Related]
5. 2-hydroxyisoquinoline-1,3(2H,4H)-diones (HIDs) as human immunodeficiency virus type 1 integrase inhibitors: Influence of the alkylcarboxamide substitution of position 4.
Billamboz M; Suchaud V; Bailly F; Lion C; Andréola ML; Christ F; Debyser Z; Cotelle P
Eur J Med Chem; 2016 Jul; 117():256-68. PubMed ID: 27105029
[TBL] [Abstract][Full Text] [Related]
6. Investigation of a novel series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones as human immunodeficiency virus type 1 integrase inhibitors.
Suchaud V; Bailly F; Lion C; Calmels C; Andréola ML; Christ F; Debyser Z; Cotelle P
J Med Chem; 2014 Jun; 57(11):4640-60. PubMed ID: 24793360
[TBL] [Abstract][Full Text] [Related]
7. Development of a series of 3-hydroxyquinolin-2(1H)-ones as selective inhibitors of HIV-1 reverse transcriptase associated RNase H activity.
Suchaud V; Bailly F; Lion C; Tramontano E; Esposito F; Corona A; Christ F; Debyser Z; Cotelle P
Bioorg Med Chem Lett; 2012 Jun; 22(12):3988-92. PubMed ID: 22607675
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human immunodeficiency virus type 1 reverse transcriptase, RNase H, and integrase activities by hydroxytropolones.
Didierjean J; Isel C; Querré F; Mouscadet JF; Aubertin AM; Valnot JY; Piettre SR; Marquet R
Antimicrob Agents Chemother; 2005 Dec; 49(12):4884-94. PubMed ID: 16304149
[TBL] [Abstract][Full Text] [Related]
9. Pharmacophore and structure-activity relationships of integrase inhibition within a dual inhibitor scaffold of HIV reverse transcriptase and integrase.
Wang Z; Tang J; Salomon CE; Dreis CD; Vince R
Bioorg Med Chem; 2010 Jun; 18(12):4202-11. PubMed ID: 20576573
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, biological evaluation and molecular modeling studies of quinolonyl diketo acid derivatives: new structural insight into the HIV-1 integrase inhibition.
Vandurm P; Guiguen A; Cauvin C; Georges B; Le Van K; Michaux C; Cardona C; Mbemba G; Mouscadet JF; Hevesi L; Van Lint C; Wouters J
Eur J Med Chem; 2011 May; 46(5):1749-56. PubMed ID: 21385662
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of dual inhibitors of HIV reverse transcriptase and integrase: introducing a diketoacid functionality into delavirdine.
Wang Z; Vince R
Bioorg Med Chem; 2008 Apr; 16(7):3587-95. PubMed ID: 18314335
[TBL] [Abstract][Full Text] [Related]
12. Rationally designed dual inhibitors of HIV reverse transcriptase and integrase.
Wang Z; Bennett EM; Wilson DJ; Salomon C; Vince R
J Med Chem; 2007 Jul; 50(15):3416-9. PubMed ID: 17608468
[TBL] [Abstract][Full Text] [Related]
13. Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site.
Neamati N; Hong H; Owen JM; Sunder S; Winslow HE; Christensen JL; Zhao H; Burke TR; Milne GW; Pommier Y
J Med Chem; 1998 Aug; 41(17):3202-9. PubMed ID: 9703465
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of 5-(1-H or 1-alkyl-5-oxopyrrolidin-3-yl)-8-hydroxy-[1,6]-naphthyridine-7-carboxamide inhibitors of HIV-1 integrase.
Melamed JY; Egbertson MS; Varga S; Vacca JP; Moyer G; Gabryelski L; Felock PJ; Stillmock KA; Witmer MV; Schleif W; Hazuda DJ; Leonard Y; Jin L; Ellis JD; Young SD
Bioorg Med Chem Lett; 2008 Oct; 18(19):5307-10. PubMed ID: 18774711
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of HQCAs with aryl or benzyl substituents on N-1 position as potential HIV-1 integrase inhibitors.
He QQ; Zhang X; Wu HQ; Gu SX; Ma XD; Yang LM; Zheng YT; Chen FE
Bioorg Med Chem; 2011 Sep; 19(18):5553-8. PubMed ID: 21862337
[TBL] [Abstract][Full Text] [Related]
16. From ligand to complexes. Part 2. Remarks on human immunodeficiency virus type 1 integrase inhibition by beta-diketo acid metal complexes.
Bacchi A; Biemmi M; Carcelli M; Carta F; Compari C; Fisicaro E; Rogolino D; Sechi M; Sippel M; Sotriffer CA; Sanchez TW; Neamati N
J Med Chem; 2008 Nov; 51(22):7253-64. PubMed ID: 18983138
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of novel indole beta-diketo acid derivatives as HIV-1 integrase inhibitors.
Sechi M; Derudas M; Dallocchio R; Dessì A; Bacchi A; Sannia L; Carta F; Palomba M; Ragab O; Chan C; Shoemaker R; Sei S; Dayam R; Neamati N
J Med Chem; 2004 Oct; 47(21):5298-310. PubMed ID: 15456274
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and anti-integrase activity of catechol-DKA hybrids.
Maurin C; Bailly F; Mbemba G; Mouscadet JF; Cotelle P
Bioorg Med Chem; 2006 May; 14(9):2978-84. PubMed ID: 16412645
[TBL] [Abstract][Full Text] [Related]
19. Molecular Docking and Molecular Dynamics Simulation Based Approach to Explore the Dual Inhibitor Against HIV-1 Reverse Transcriptase and Integrase.
Chander S; Pandey RK; Penta A; Choudhary BS; Sharma M; Malik R; Prajapati VK; Murugesan S
Comb Chem High Throughput Screen; 2017; 20(8):734-746. PubMed ID: 28641512
[TBL] [Abstract][Full Text] [Related]
20. Active site binding modes of dimeric phloroglucinols for HIV-1 reverse transcriptase, protease and integrase.
Gupta P; Kumar R; Garg P; Singh IP
Bioorg Med Chem Lett; 2010 Aug; 20(15):4427-31. PubMed ID: 20594846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]